Abstract
Background: COVID-19 vaccine booster dose hesitancy amongst the Saudi Arabia population is a concern. The objectives of the study were to explore the Saudi public’s willingness to receive a COVID-19 vaccine booster dose and identify the factors affecting their willingness. Methods: From December 2021 to March 2022, an online cross-sectional survey using an anonymous, structured, and self-administered questionnaire was conducted among members of the Saudi public aged ≥18 years who did not receive a COVID-19 vaccine booster dose. Results: Of the 2101 respondents, 86.8% expressed a willingness to receive a COVID-19 vaccine booster dose. Multiple logistic regression analysis showed that age (18 to 25 years) (adjusted odds ratio [aOR] = 2.54; 95% confidence interval [95% CI] = 1.14–5.74), being single (aOR = 2.85; 95% Cl = 1.42–5.72), and prior receipt of an influenza vaccine (aOR = 2.45; 95% Cl = 1.80–3.34) were significantly associated with participants’ willingness to receive the COVID-19 vaccine booster dose. Having a bachelor’s degree or above (aOR = 0.95; 95% CI = 0.81–0.99) and not following COVID-19 news (aOR = 0.70; 95% CI = 0.52–0.89) were associated with a significant likelihood of having no intention to receive the COVID-19 vaccine boosters. Conclusions: Most Saudi people were willing to have the COVID-19 vaccine booster dose, with age and prior influenza vaccination as the predictors; paradoxically, a university-level qualification was a barrier.
Subject
Management, Monitoring, Policy and Law,Renewable Energy, Sustainability and the Environment,Geography, Planning and Development,Building and Construction
Reference36 articles.
1. Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients;Aljunaid;J. Fam. Med. Prim. Care,2022
2. (2022, November 29). WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/.
3. Alkhormi, A.H., Mahfouz, M.S., Alshahrani, N.Z., Hummadi, A., Hakami, W.A., Alattas, D.H., Alhafaf, H.Q., Kardly, L.E., and Mashhoor, M.A. (2022). Psychological Health and Diabetes Self-Management among Patients with Type 2 Diabetes during COVID-19 in the Southwest of Saudi Arabia. Medicina, 58.
4. Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward;Assiri;Travel Med. Infect. Dis.,2021
5. Saudi Press Agency (2022, May 21). SFDA Approves Registration of Pfizer-BioNTech COVID-19 Vaccine, Available online: https://www.spa.gov.sa/viewfullstory.php?lang=en&newsid=2166947.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献